Veerhealth Care Ltd has announced the appointment of Ms. Ashita Chittora as the company's new Company Secretary and Compliance Officer, following a board meeting held on February 02, 2026. The appointment takes effect immediately from the same date and was made in compliance with regulatory requirements under the Companies Act, 2013 and SEBI regulations.

Board Meeting Details

The board meeting that approved this appointment commenced at 02.00 P.M. and concluded at 02.30 P.M. on February 02, 2026. The decision was made in accordance with the provisions of Section 203 of the Companies Act, 2013, and Rule made thereunder, as well as Regulation 6 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointee Profile and Qualifications

Ms. Ashita Chittora brings substantial expertise to her new role as Company Secretary and Compliance Officer. She is an Associate Member of the Institute of Company Secretaries of India with membership number A50327, possessing requisite qualifications and skills in secretarial compliances.

Ms. Chittora has undertaken various assignments and possesses good experience in Corporate Law and Listing Regulations, making her well-suited for the compliance responsibilities at Veerhealth Care Ltd.

Regulatory Compliance

The appointment has been made in full compliance with regulatory requirements under Regulation 6(1) & 30(4) read with Para A of Part A of Schedule II of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The company has provided all details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Company Information

Veerhealth Care Ltd operates from its registered office at 629-A Gazdar House, 1st Floor, Near Kalbadevi Post Office, J.S.S. Marg, Mumbai - 400 002. The company also has manufacturing works located at Plot No. 224, Vibrant Business Park, Opp UPL, National Highway No. 8, Vapi - 396191, Gujarat. The announcement was signed by Managing Director Bhavin Satish Shah (DIN: 03129574), who requested BSE Limited to update their records accordingly.

Veerhealth Care Limited announced on January 9, 2026, that it has secured a manufacturing order worth ₹1.72 crores from one of India's leading FMCG companies. The order involves manufacturing and supply of face care products under the private label category, marking a significant business development for the company.

Order Details and Specifications

The comprehensive order details reveal the scope and nature of this business opportunity:

Regulatory Compliance and Transparency

As per SEBI regulations under Regulation 30 of SEBI (LODR) Regulations, 2015, Veerhealth Care Limited has provided detailed disclosures about the order. The client's identity remains confidential as per the terms of the agreement. The company confirmed that this is a domestic order with no related party transactions involved.

Business Impact and Growth Prospects

The management expressed optimism about this development, stating that the new order represents a significant opportunity for the company. They anticipate additional growth in turnover as a result of this partnership with the leading consumer supply company in the face care range category.

Corporate Governance Aspects

The company has confirmed several important governance parameters:

• No promoter or group company interest in the awarding entity
• No related party transaction implications
• Arms-length transaction compliance maintained
• Full regulatory disclosure provided as per SEBI guidelines

This order demonstrates Veerhealth Care Limited's capability in the private label manufacturing segment and its ability to secure contracts from established FMCG players in the Indian market. The 30-day execution timeline indicates the company's operational readiness to fulfill large-scale manufacturing requirements efficiently.